Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Arthritis and Arthritic Pain Clinical Trials

A listing of Arthritis and Arthritic Pain medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (6) clinical trials

The purpose of this study is to provide 24 - 52 week efficacy, safety and tolerability data, as well as up to 3.5-year efficacy, safety and tolerability data in subjects with active Psoriatic Arthritis despite current or previous nonsteroidal anti-inflammatory drug (NSAID), disease-modifying antirheumatic drug (DMARD) therapy and/or previous anti-tumor ...


Disodium Zoledronate Tetrahydrate is a drug being studied to see how effective it is at relieving osteoarthritis pain of the knee. Disodium Zoledronate Tetrahydrate is an oral pill taken once a week. Study participants will be required to take daily calcium and Vitamin D during the study. The calcium and ...


This is A randomized, double-blind, placebo-controlled, multicenter, parallel-group, study of the efficacy and safety of Tanezumab when administered by SC injection for 16 weeks compared to placebo in subjects osteoarthritis of the Knee or hip. Subjects will receive a total of two injections, separated by 8 weeks.


The purpose of this study is to evaluate the safety and effectiveness of a new experimental medication for the treatment of moderate to severe osteoarthritis of the hip or knee.


We are currently looking for study participants who have been diagnosed with Osteoarthritis of the Knee or Lumbar Spine (Low Back).


Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia

This is a randomised double-blinded placebo-controlled multi centre study in 98 patients with ACPA positive arthralgia. The study is composed of 2 arms with a 1:1 randomisation at baseline: Treatment phase will be 6 months. Group 1: Abatacept s.c. 125 mg weekly for 6 months vs. Group 2: Placebo s.c. ...